{
    "code": "01026794",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026794",
    "time": "2022-01-28 03:12:21",
    "許可證字號": "衛署藥製字第026794號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "108\/05\/17",
    "發證\/登錄日期": "72\/02\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102679403",
    "中文品名": "&quot;國信&quot;布朗信錠１２公絲",
    "英文品名": "BROMHEXINE TABLETS 12MG",
    "適應症": "下列疾患及狀態所伴有之喀痰喀出困難、急慢性支氣管炎、手術後支氣管擴張",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BROMHEXINE HCL",
    "限制項目": "09委託製造 1R不得製造",
    "申請商名稱": "1101417200  國信藥品股份有限公司",
    "申請商地址": "嘉義市西區新民路115號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800000310",
            "成分名稱": "BROMHEXINE HCL",
            "含量描述": "12",
            "含量": "12.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "2620-Bromhexine Tab 12mg-104-12-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026794&Seq=001&Type=9"
        }
    ]
}